May 06, 2020

Areva Pharmaceuticals is excited to announce three new products to our ever-expanding portfolio:

May 06, 2020

Areva Pharmaceuticals would like to announce the addition of Irinotecan HCL Injection 300mg/15ml to our existing Irinotecan family that includes 40mg/2ml and 100mg/5ml.

Mar 06, 2019

Areva Pharmaceuticals Announces the Launch Temozolomide USP

Jul 27, 2015

Ernst & Young announces Areva Pharmaceuticals Founder & CEO Victor Swaminathan as an EY Entrepreneur Of The Year® 2015 Award finalist in Ohio Valley

Dec 19, 2014

Areva Pharmaceuticals was granted VAWD accreditation by NABP (National Association of Boards of Pharmacy)

Jul 21, 2014

Areva Pharmaceuticals was pleased to announce it was awarded contracts by Amerinet for Irinotecan and Pamidronate.

May 16, 2014

Areva Pharmaceuticals owners and community leaders were joined by residents of the Lanesville Indiana and outlying communities for a ribbon cutting ceremony and open house.

May 03, 2013

Areva Pharmaceuticals was awarded a contract with Apexus for Epirubicin, Irinotecan, and Pamidronate.

Mar 05, 2013

Local Community Rolls Out Red Carpet for Areva

Areva Gallery